CorDynamics offers a variety of discovery models designed to investigate thrombosis and putative anti-thrombotics. These customized assessments leverage physiologically relevant paradigms with expert design and follow through to enable key lead optimization in drug discovery.
Our experience with these thrombosis models enables us to interrogate the effects of new compounds in multiple modes.
Platelet aggregation assessments (whole blood and PRP)
In vitro and in vivo paradigms
Carotid and coronary arterial thrombosis
Pharmacokinetic / pharmacodynamic readouts
All our studies, throughout your drug discovery steps, can be efficiently designed using the highest scientific rigor coupled with a quick turnaround time.